Form D · Biotechnology
Vindico NanoBioTechnology, Inc.
Lexington, KY · CIK 0001634988
Offering snapshot reported Feb 25, 2015 · SEC filing
- Reported sold
- $1.29M Offering amount: $2M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Feb 13, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2015 | Initial | $1,285,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-234761
Source: Form D, filed Feb 25, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paiman Peter Ghoroghchian | Director, Executive |
| Eric M Ostertag | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
535 W 2 Nd Street Suite 10
Lexington, KY, 40508
Lexington, KY, 40508